Evidence check: tTG IgA in the context of blood sugar

The tTG IgA test (tissue transglutaminase antibodies) is the primary serological marker for celiac disease, not directly for blood sugar. A positive result indicates an autoimmune reaction to gluten. However, there is a well-established association between celiac disease and type 1 diabetes (both autoimmune conditions). In undiagnosed or untreated celiac disease, chronic intestinal inflammation can impair nutrient absorption, indirectly affecting blood sugar regulation (e.g., through carbohydrate malabsorption or iron deficiency). Nevertheless, tTG IgA is not a blood sugar marker. The evidence for a direct link to blood glucose levels is weak and indirect. Elevated tTG IgA should always be evaluated for celiac disease (including duodenal biopsy). In individuals with known diabetes or blood sugar issues, tTG IgA testing is reasonable to rule out concurrent celiac disease. Without relevant symptoms or risk factors, the test is not indicated for blood sugar questions. Evidence: human-strong for celiac, but for blood sugar context mixed/unclear.